Skip to main content
AXTI $81.64 +5.41%
AXTI logo

AXTI · Axt Inc

Track AXTI — free
$81.64 +4.19 (+5.41%) At close · Aug 14
Market Cap
$5.35B
Shares
65.57M
All earnings calls

Earnings call · FY2026 Q1

Axt Inc Q1 FY2026 Earnings Call

Axt Inc Q1 FY2026 Earnings Call

Concluded Apr 30, 2026 Audio replay
Apr 30, 2026 54:45 55 turns
Period
FY2026 Q1
Runtime
54:45
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

AXT posted Q1 2026 revenue of $26.9 million, up from $23 million in Q4 2025, with non-GAAP gross margin expanding to 29.9% and the company narrowing its non-GAAP net loss to $0.585 million ($0.01/share) as it scales indium phosphide capacity to meet surging AI-driven optical demand.

Indium Phosphide Capacity Expansion 95 Product Mix and Wafer Sizes 40 China Demand and Geopolitics 34 Gross Margin Trajectory 18 AI / Data Center Demand 15 Tongmei IPO 10

Management tone

Confident

Net tone +70 · moderate hedging

Grounding quotes
  • “This is an incredibly exciting time for AXT, Inc.”
  • “With our backlog of orders and customer forecasts achieving record levels, we are laser focused on adding capacity to support customer requirements.”
  • “I am pleased to report that we are running ahead of our plan to double our indium phosphide capacity this year from 2025 levels.”
  • “we believe we are in the best position competitively to support and enable our industry in meeting its current and future needs.”

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $26.92M +39.1% YoY
Diluted EPS -$0.03
Gross margin 29.6% +36.0 pp YoY
Net income -$1.62M

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Revenue grew to $26.9M in Q1 2026 from $23.0M in Q4 2025, with indium phosphide revenue of $13.6M driven by data center applications
  • Non-GAAP gross margin expanded sharply to 29.9% from 21.5% in Q4 2025 and a negative 6.1% a year ago; GAAP gross margin reached 29.6%
  • Non-GAAP net loss narrowed to $0.585M ($0.01/share) from $2.3M ($0.05/share) in Q4 2025 and $8.2M ($0.19/share) a year ago
  • Closed a $632.5M capital raise to fund Tongmei indium phosphide capacity expansion and R&D for 6-inch wafers
  • Running ahead of plan to double indium phosphide capacity in 2026 vs. 2025, with plans to double again in 2027 at a new facility and further meaningful expansion in 2028
  • Industry sources and customers expect a 4x to 6x substrate market increase over the next three to five years driven by scale-out and scale-up, including co-packaged optics beginning late 2027

Risks & pressure points

  • Cash, cash equivalents and investments decreased by $5.1M sequentially to $123M as of March 31, with net inventory rising approximately $8.5M to $90.2M
  • Geopolitical environment and China export permit requirements remain risks to the Tongmei STAR Market IPO and to operations
  • Significant CapEx ahead: ~$30-40M this year, ~$100M in 2027, and a potential greenfield site of ~$220-250M beyond
  • Q1 8-K disclosed anticipated revenue range of $26-28M and net loss of $1.6-2.6M ($0.03-0.05/share), reflecting quarter-end uncertainty before final close
  • Still operating at a GAAP net loss of $1.6M ($0.03/share) and non-GAAP operating loss of $0.55M in Q1

Key moments

Jump directly to management's words in the synchronized transcript.

“Q2 would be expected to be our largest quarter for indium phosphide in AXT, Inc.'s history. This derives from an indium phosphide backlog that has now reached a new high of over $100 million.” Speaker 3, CEO

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Substrates$19.28M +74% YoY
Raw Materials and Other$7.64M -7.6% YoY
Full-screen source Call document